Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$11.6M Sell
69,441
-583
-0.8% -$97.5K 0.82% 37
2026
Q1
$12.1M Buy
70,024
+44,249
+172% +$7.96M 0.97% 36
2025
Q4
$4.78M Sell
25,775
-46,609
-64% -$8.71M 0.36% 64
2025
Q3
$14.6M Sell
72,384
-787
-1% -$162K 1.07% 29
2025
Q2
$16M Sell
73,171
-873
-1% -$197K 1.24% 25
2025
Q1
$18.1M Sell
74,044
-204
-0.3% -$46.3K 1.53% 15
2024
Q4
$15.8M Buy
74,248
+287
+0.4% +$63.7K 1.3% 25
2024
Q3
$16.5M Buy
73,961
+69
+0.1% +$15.3K 1.37% 26
2024
Q2
$15.6M Sell
73,892
-3,343
-4% -$687K 1.38% 25
2024
Q1
$15.9M Buy
77,235
+5,052
+7% +$1.01M 1.46% 27
2023
Q4
$13.7M Buy
+72,183
New +$13.9M 1.53% 26

Other funds holding MRSH

Nixon Peabody Trust's MRSH Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Marsh (MRSH) stake by 0.83% in Q2 2026, selling an estimated $97.5K and leaving 69,441 shares worth $11.6M. The position accounts for 0.82% of the portfolio, ranked #37.

Nixon Peabody Trust first reported a position in MRSH in Q4 2023 and has held it in 11 quarters since. The position peaked at $18.1M in Q1 2025. 602 funds tracked by Wall St. Rank hold MRSH as of Q2 2026.

  • Nixon Peabody Trust held 69,441 shares of Marsh worth $11.6M as of Q2 2026.
  • Nixon Peabody Trust sold 583 Marsh shares in Q2 2026, an estimated $97.5K.
  • Marsh made up 0.82% of Nixon Peabody Trust's portfolio in Q2 2026, its #37 holding.
  • Nixon Peabody Trust first reported a position in Marsh in Q4 2023 and has held it in 11 quarters since.
  • Nixon Peabody Trust's Marsh position peaked at $18.1M in Q1 2025.
  • 602 funds tracked by Wall St. Rank held Marsh as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.